Consumer Information Transparency

Consumer Information Transparency is a formal construct within pharmaceutical and regulatory science that denotes the systematic and accessible disclosure of inactive ingredients in drug products to end users, distinguished by its focus on empowering informed consumer decision-making through accurate, standardized, and publicly available formulation data.

104

Publications

8.2K

Citations

264

Authors

165

Institutions

Publications per year

2017–2026

67

Authors

264

  1. GB
    Gargi Bhaduri

    Kent State University, United States

    4 publications · 278 citations

    4

    h-index

  2. LK
    Leslie K. John

    Harvard University, United States

    3 publications · 369 citations

    3

    h-index

  3. JH
    Jung Ha‐Brookshire

    University of Missouri, United States

    3 publications · 254 citations

    3

    h-index

  4. RW
    Ryan W. Buell

    Harvard University, United States

    2 publications · 116 citations

    2

    h-index

  5. II
    Ibrahim Ilahi

    University of Toronto, Canada

    2 publications · 75 citations

    2

    h-index

1–5 of 264

Venues

  1. Journal of Marketing

    JM · 5 publications · 202 citations

    5

    h-index

  2. SSRN Electronic Journal

    Repository · 5 publications · 107 citations

    5

    h-index

  3. Journal of Marketing Research

    3 publications · 212 citations

    3

    h-index

  4. Journal of Consumer Affairs

    JCA · 3 publications · 151 citations

    3

    h-index

  5. Behavioural Public Policy

    BPP · 2 publications · 42 citations

    2

    h-index

1–5